In vitro and ex vivo research services
for food supplements, pharmaceuticals and more!
VivaCell stands for Quality in vitro and ex vivo research services in pharmaceuticals, nutraceuticals (human/animals), natural products and cosmetics and oral care products. Since the beginning of 2025 we’re part of the CDMO (Contract Development & Manufacturing Organization) group 1Q Health GmbH.
Latest News
VivaCell is part of the CDMO group 1Q Health
A new chapter awaits us as a member of 1Q Health In April 2025 we joined 1Q Health Group, [...]
Recent Publication
Cimicifuga racemosa extract Ze 450 shifts macrophage immunometabolism and attenuates pro-inflammatory signaling
Sponsoring
VivaCell Biotechnology ist jetzt Team-Sponsor des SC Freiburg. Gerne unterstützen wir die Arbeit des SC Freiburg und wünschen Mannschaft, [...]
Novobiome project consortium
Granted with Eureka Eurostars funding (E!11342)
Recent Publication
Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes
Recent Publication
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice
Vivacell is a partner in the interdisciplinary research project “ASPIRANT”
(Text in German) Pünktlich zum Wissenschaftsjahr 2020 Bioökonomie fiel am 1. Februar 2020 der Startschuss für das Projekt "ASPIRANT" …
Recent Publication
2LARTH®, a micro-immunotherapy medicine, exerts anti-inflammatory effects in vitro and reduces TNF-α and IL-1β secretion
Recent Publication
Ex vivo anti-inflammatory effects of probiotics for periodontal health
VivaCell Quality Certificate
Use our scientific certificate to demontsrate that the health benefits were approved and validate by us.
Awarded by “Stifterverband”
We were awarded the Stifterverband's "Innovative through Research" for our research activities.